Advanced search
Publication Cover
Upsala Journal of Medical Sciences Volume 124, 2019 - Issue 1: Uppsala Clinical Research Center - World-leading support for clinical sciences. Guest edited by Lars Berglund, Stefan James, and Johan Sundström
Journal homepage
1,465
Views
3
CrossRef citations to date
0
Altmetric
Article

The Precision HYpertenSIon Care (PHYSIC) study: a double-blind, randomized, repeated cross-over study

Johan SundströmDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden; ;Uppsala Clinical Research Center (UCR), Uppsala, SwedenCorrespondence[email protected]
View further author information
,
Lars LindDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden; View further author information
,
Shamim NowrouziDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden; View further author information
,
Per LytsyDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden; ORCID Iconhttp://orcid.org/0000-0003-1949-6299View further author information
ORCID Icon,
Kerstin MarttalaDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden; View further author information
,
Inger EkmanUppsala Clinical Research Center (UCR), Uppsala, SwedenView further author information
,
Patrik ÖhagenUppsala Clinical Research Center (UCR), Uppsala, SwedenView further author information
&
Ollie ÖstlundUppsala Clinical Research Center (UCR), Uppsala, SwedenView further author information
 show all
Pages 51-58 | Received 17 Jun 2018, Accepted 05 Jul 2018, Published online: 28 Sep 2018

References

  • Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–60.
  • Hodgson TA, Cai L. Medical care expenditures for hypertension, its complications, and its comorbidities. Med Care. 2001;39:599–615.
  • Rahimi K, MacMahon S. Blood pressure management in the 21st century: maximizing gains and minimizing waste. Circulation. 2013;128:2283–5.
  • Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet. 2000;356:1955–64.
  • World Health Organization. Adherence to long-term therapies: evidence for action. Geneva, Switzerland: World Health Organization; 2003.
  • Bell KJ, Hayen A, Macaskill P, Craig JC, Neal BC, Irwig L. Mixed models showed no need for initial response monitoring after starting antihypertensive therapy. J Clin Epidemiol. 2009;62:650–9.
  • Senn S. Mastering variation: variance components and personalised medicine. Stat Med. 2016;35:966–77.
  • Bell KJ, Hayen A, Macaskill P, Craig JC, Neal BC, Fox KM, et al. Monitoring initial response to Angiotensin-converting enzyme inhibitor-based regimens: an individual patient data meta-analysis from randomized, placebo-controlled trials. Hypertens. 2010;56:533–9.
  • Dickerson JE, Hingorani AD, Ashby MJ, Palmer CR, Brown MJ. Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet. 1999;353:2008–13.
  • Laverman GD, de Zeeuw D, Navis G. Between-patient differences in the renal response to renin-angiotensin system intervention: clue to optimising renoprotective therapy? J Renin Angiotensin Aldosterone Syst. 2002;3:205–13.
  • Senn S, Rolfe K, Julious SA. Investigating variability in patient response to treatment-a case study from a replicate cross-over study. Stat Methods Med Res. 2011;20:657–66.
  • Senn S. Individual therapy: new dawn or false dawn. Ther Innov Regul Sci. 2001;35:1479–94.
  • James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507–20.
  • Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–219.
  • Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials; Board on Health Care Services; Board on Health Sciences Policy; Institute of Medicine. Evolution of translational omics: lessons learned and the path forward. Washington, DC: National Academies Press (US); 2012.
  • Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Soft. 2015;67:48.
  • Halekoh U, Højsgaard S. A Kenward-Roger approximation and parametric bootstrap methods for tests in linear mixed models – the R Package pbkrtest. J Stat Soft. 2014;59:1–30.
  • Scuffham PA, Nikles J, Mitchell GK, Yelland MJ, Vine N, Poulos CJ, et al. Using N-of-1 trials to improve patient management and save costs. J Gen Intern Med. 2010;25:906–13.
  • Araujo A, Julious S, Senn S. Understanding variation in sets of N-of-1 trials. PLoS One. 2016;11:e0167167

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.